Related Experiment Video
Updated: Dec 8, 2025
11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.5K
Crosswalk EQ-5D-5L Value Set for Slovenia
Valentina Prevolnik Rupel1, Marko Ogorevc1
1Institute for Economic Research, Kardeljeva ploščad 17, 1000 Ljubljana, Slovenia.
Zdravstveno Varstvo
|September 21, 2020
Summary
An interim EQ-5D-5L value set for Slovenia was estimated using crosswalk methodology. This provides interim health state values until a Slovenian EQ-5D-5L value set is directly derived.
Area of Science:
- Health Economics
- Psychometrics
- Quality of Life Research
Background:
- The EQ-5D-5L instrument is widely used in Slovenia, but a specific value set is lacking.
- Existing EQ-5D-3L value sets limit the accurate valuation of health profiles.
- This necessitates the development of an interim EQ-5D-5L value set for Slovenia.
Purpose of the Study:
- To estimate an interim EQ-5D-5L value set for Slovenia using the crosswalk methodology.
- To compare the interim EQ-5D-5L values with the existing Slovenian EQ-5D-3L values.
Main Methods:
- Applied the EuroQol Group's crosswalk methodology to the Slovenian EQ-5D-3L TTO value set.
- Compared mean scores and distribution of values between EQ-5D-3L and the interim EQ-5D-5L values.
Main Results:
- The EQ-5D-5L version includes "slight" and "severe" health state levels, expanding the scale's range.
- The 5-level version results in fewer health states valued below 0 and above 0.8 compared to the 3-level version.
- Identified corresponding health states between EQ-5D-3L (22222) and EQ-5D-5L (33333).
Conclusions:
- The interim EQ-5D-5L value set, derived via crosswalk, is recommended for use in Slovenia.
- This interim set should be utilized until a value set is developed from direct Slovenian population preferences.
- This approach ensures continued use of EQ-5D-5L in Slovenia for health state valuation.
More Related Videos
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.2K
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
10.1K
Related Concept Videos
01:13Bioequivalence studies: Biowaivers
109
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
109
01:20Integrated Healthcare System
2.1K
An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
2.1K
01:11Secondary Healthcare System
1.8K
Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.8K
01:26Pharmaceutical Equivalents
107
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
107
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
102
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
102
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
80
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
80